Design Therapeutics, Inc.
DSGN
$4.72
-$0.24-4.84%
| Weiss Ratings | DSGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | DSGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | DSGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 2.29 | |||
| Price History | DSGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -6.35% | |||
| 30-Day Total Return | -4.45% | |||
| 60-Day Total Return | -23.13% | |||
| 90-Day Total Return | -15.26% | |||
| Year to Date Total Return | -23.50% | |||
| 1-Year Total Return | 76.12% | |||
| 2-Year Total Return | -33.05% | |||
| 3-Year Total Return | -72.15% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -36.16% | |||
| 52-Week Low % Change | 102.44% | |||
| Price | DSGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $7.77 | |||
| 52-Week Low Price | $2.45 | |||
| 52-Week Low Price (Date) | Mar 18, 2024 | |||
| 52-Week High Price (Date) | Nov 13, 2024 | |||
| Valuation | DSGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 281.54M | |||
| Enterprise Value | 38.40M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.88 | |||
| Earnings Per Share Growth | -26.65% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | 1.16 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $4.72 | |||
| Enterprise Value/EBITDA (TTM) | -0.62 | |||
| Enterprise Value/EBIT | -0.62 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | DSGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 56.68M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | DSGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 858 293 4900 | |||
| Address | 6005 Hidden Valley Road Carlsbad, CA 92011 | |||
| Website | www.designtx.com | |||
| Country | United States | |||
| Year Founded | 2017 | |||
| Profitability | DSGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | DSGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -14.39% | |||
| Return on Equity | -- | |||
| Income Statement | DSGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -35.42M | |||
| EBITDA (TTM) | -61.79M | |||
| EBIT (TTM) | -62.38M | |||
| Net Income (TTM) | -49.59M | |||
| Net Income Avl. to Common (TTM) | -49.59M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | -15.28% | |||
| EPS Diluted (TTM) | -0.88 | |||
| EPS Diluted Growth (Q YOY) | -14.07% | |||
| Balance Sheet | DSGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 245.48M | |||
| Cash Per Share (Q) | $4.33 | |||
| Total Current Assets (Q) | 248.04M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 242.10M | |||
| Current Ratio (Q) | 29.312 | |||
| Book Value Per Share (Q) | $4.27 | |||
| Total Assets (Q) | 252.09M | |||
| Total Current Liabilities (Q) | 8.46M | |||
| Total Debt (Q) | 2.33M | |||
| Total Liabilities (Q) | 10.00M | |||
| Total Common Equity (Q) | 242.10M | |||
| Cash Flow | DSGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 43.96M | |||
| Cash from Financing (TTM) | 513.00K | |||
| Net Change in Cash (TTM) | 1.36M | |||
| Levered Free Cash Flow (TTM) | -26.68M | |||
| Cash from Operations (TTM) | -43.11M | |||
